| | Other Issues: previous | next | latest | archiveCommentaries Surgery vs. radiotherapy in localized prostate cancer. Which is best? Stefan Welz, Maximilian Nyazi, Claus Belka, and Ute Ganswindt PMCID: PMC2553076 SCLC extensive disease – treatment guidance by extent or/and biology of response? Franziska Eckert and Arndt-Christian Müller PMCID: PMC2570671 Methodology Testing the portal imager GLAaS algorithm for machine quality assurance G Nicolini, E Vanetti, A Clivio, A Fogliata, G Boka, and L Cozzi PMCID: PMC2430969 The GLAaS algorithm for portal dosimetry and quality assurance of RapidArc, an intensity modulated rotational therapy Giorgia Nicolini, Eugenio Vanetti, Alessandro Clivio, Antonella Fogliata, Stine Korreman, Jiri Bocanek, and Luca Cozzi PMCID: PMC2553075 Research Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer Jasper Yuen, George Rodrigues, Kristina Trenka, Terry Coad, Slav Yartsev, David D'Souza, Michael Lock, and Glenn Bauman PMCID: PMC2249591 Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs? Carsten Nieder, Adam Pawinski, Nicolaus H Andratschke, and Michael Molls PMCID: PMC2249590 Does Intensity Modulated Radiation Therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only? Matthias Guckenberger, Kurt Baier, Anne Richter, Dirk Vordermark, and Michael Flentje PMCID: PMC2253547 Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons Zahra Taheri-Kadkhoda, Thomas Björk-Eriksson, Simeon Nill, Jan J Wilkens, Uwe Oelfke, Karl-Axel Johansson, Peter E Huber, and Marc W Münter PMCID: PMC2265732 Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapy Hans Paul van der Laan, Wil V Dolsma, John H Maduro, Erik W Korevaar, and Johannes A Langendijk PMCID: PMC2270860 Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy Matthew Beasley, Scott G Williams, Tom Pickles, and The BCCA Prostate Outcomes Unit PMCID: PMC2358899 High-dose-rate brachytherapy for soft tissue sarcoma in children: a single institution experience Gustavo A Viani, Paulo E Novaes, Alexandre A Jacinto, Celia B Antonelli, Antonio Cassio A Pellizzon, Elisa Y Saito, and João V Salvajoli PMCID: PMC2359754 Conventionally-fractionated image-guided intensity modulated radiotherapy (IG-IMRT): a safe and effective treatment for cancer spinal metastasis Youling Gong, Jin Wang, Sen Bai, Xiaoqin Jiang, and Feng Xu PMCID: PMC2373792 The effect of radio-adaptive doses on HT29 and GM637 cells Silke B Schwarz, Pamela M Schaffer, Ulrike Kulka, Birgit Ertl-Wagner, Roswitha Hell, and Moshe Schaffer PMCID: PMC2387149 Reproducibility and geometric accuracy of the fixster system during hypofractionated stereotactic radiotherapy Peter Lindvall, Per Bergström, Per-Olov Löfroth, Roger Henriksson, and A Tommy Bergenheim PMCID: PMC2423357 A psychoeducational intervention reduces the need for anesthesia during radiotherapy for young childhood cancer patients Sonja Haeberli, Michael A Grotzer, Felix K Niggli, Markus A Landolt, Claudia Linsenmeier, Roland A Ammann, and Nicole Bodmer PMCID: PMC2430970 In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol Robert Michael Hermann, Hendrik Andreas Wolff, Hubertus Jarry, Paul Thelen, Carsten Gruendker, Margret Rave-Fraenk, Heinz Schmidberger, and Hans Christiansen PMCID: PMC2490684 Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT) Kurian Jones Joseph, Riaz Alvi, David Skarsgard, Jon Tonita, Nadeem Pervez, Cormac Small, and Patricia Tai PMCID: PMC2494997 Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose Danny Schuring and Coen W Hurkmans PMCID: PMC2515326 Prevention of radiochemotherapy-induced toxicity with amifostine in patients with malignant orbital tumors involving the lacrimal gland: a pilot study David Goldblum, Pirus Ghadjar, Juergen Curschmann, Richard Greiner, and Daniel Aebersold PMCID: PMC2542992 Reirradiation of recurrent breast cancer with and without concurrent chemotherapy Florian Würschmidt, Jörg Dahle, Cordula Petersen, Claudia Wenzel, Matthias Kretschmer, and Christoph Bastian PMCID: PMC2556652 A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma Tom Budiharto, Karin Haustermans, Eric Van Cutsem, Werner Van Steenbergen, Baki Topal, Raymond Aerts, Nadine Ectors, Didier Bielen, Dirk Vanbeckevoort, Laurence Goethals, and Chris Verslype PMCID: PMC2557003 Impact of different leaf velocities and dose rates on the number of monitor units and the dose-volume-histograms using intensity modulated radiotherapy with sliding-window technique Hilke Vorwerk, Daniela Wagner, and Clemens F Hess PMCID: PMC2561032 The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group Prakash Chinnaiyan, Meihua Wang, Amyn M Rojiani, Philip J Tofilon, Arnab Chakravarti, K Kian Ang, Hua-Zhong Zhang, Elizabeth Hammond, Walter Curran, Jr, and Minesh P Mehta PMCID: PMC2563009 Motion compensation with a scanned ion beam: a technical feasibility study Sven Oliver Grözinger, Christoph Bert, Thomas Haberer, Gerhard Kraft, and Eike Rietzel PMCID: PMC2576303 Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking Pirus Ghadjar, Jacqueline Vock, Daniel Vetterli, Peter Manser, Roland Bigler, Jan Tille, Axel Madlung, Frank Behrensmeier, Roberto Mini, and Daniel M Aebersold PMCID: PMC2613141 Intrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with Cone-beam CT Judit Boda-Heggemann, Frederick Marc Köhler, Hansjörg Wertz, Michael Ehmann, Brigitte Hermann, Nadja Riesenacker, Beate Küpper, Frank Lohr, and Frederik Wenz PMCID: PMC2588616 Pre-segmented 2-Step IMRT with subsequent direct machine parameter optimisation – a planning study Klaus Bratengeier, Jürgen Meyer, and Michael Flentje PMCID: PMC2612672 Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields Alexandra J Stewart, Desmond A O'Farrell, Robert A Cormack, Jorgen L Hansen, Atif J Khan, Subhakar Mutyala, and Phillip M Devlin PMCID: PMC2612673 Radiation-induced skin injury in the animal model of scleroderma: implications for post-radiotherapy fibrosis Sanath Kumar, Andrew Kolozsvary, Robert Kohl, Mei Lu, Stephen Brown, and Jae Ho Kim PMCID: PMC2599892 Outcome in recurrent head neck cancer treated with salvage-IMRT Gabriela Studer, Klaus W Graetz, and Christoph Glanzmann PMCID: PMC2621229 Reviews The impact of functional imaging on radiation medicine Nidhi Sharma, Donald Neumann, and Roger Macklis PMCID: PMC2553402 Neuropsychological testing and biomarkers in the management of brain metastases Andrew Baschnagel, Pamela L Wolters, and Kevin Camphausen PMCID: PMC2556333 Normal tissue toxicity after small field hypofractionated stereotactic body radiation Michael T Milano, Louis S Constine, and Paul Okunieff PMCID: PMC2596155 Short Reports Severe skin reaction secondary to concomitant radiotherapy plus cetuximab Bernhard Berger and Claus Belka PMCID: PMC2248588 Highly proliferative neuroendocrine carcinoma – influence of radiotherapy fractionation on tumor response Anne Hansen Ree PMCID: PMC2397422 High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients Irene M Lips, Homan Dehnad, Carla H van Gils, Arto E Boeken Kruger, Uulke A van der Heide, and Marco van Vulpen PMCID: PMC2430572 Effect of prolonging radiation delivery time on retention of gammaH2AX Vitali Moiseenko, Judit P Banáth, Cheryl Duzenli, and Peggy L Olive PMCID: PMC2459198 Study Protocol High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina Sushil Beriwal, Dwight E Heron, Robert Mogus, Robert P Edwards, Joseph L Kelley, and Paniti Sukumvanich PMCID: PMC2270281 Study protocol of the German "Registry for the Detection of Late Sequelae after Radiotherapy in Childhood and Adolescence" (RiSK) Tobias Bolling, Andreas Schuck, Hildegard Pape, Christian Rube, Barbara Pollinger, Beate Timmermann, Rolf D Kortmann, Karin Dieckmann, and Normann Willich PMCID: PMC2373793 Randomized multicenter trial on the effect of radiotherapy for plantar Fasciitis (painful heel spur) using very low doses – a study protocol Marcus Niewald, M Heinrich Seegenschmiedt, Oliver Micke, Stefan Gräber, and the GCGBD (German cooperative group on the radiotherapy for benign diseases) of the DEGRO (German society for radiation oncology) PMCID: PMC2557002 FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma Letizia Deantonio, Debora Beldì, Giuseppina Gambaro, Gianfranco Loi, Marco Brambilla, Eugenio Inglese, and Marco Krengli PMCID: PMC2559840 |
